Apogee Therapeutics Inc (APGE)

Investing Cash Flow

-$687.89M

TTM · Period ending: · USD

APGE logo

APGE Investing Cash Flow

Latest reported-$687.89M
APGE TTM Cash from Investing ($0.00 → -$687.89M)
High-resolution chart · PNG

APGE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Apogee Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-687,893,000
-227,905,000
-179,574,000
155,419,000
-8,904,000
-235,737,000
-300,462,000
-620,739,000
-708,579,000
-559,871,000
-508,128,000
-234,218,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.